| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |